Utilization management opportunities for palivizumab for prophylaxis of respiratory syncytial virus complications in infants
- PMID: 20044846
- PMCID: PMC10437723
- DOI: 10.18553/jmcp.2010.16.1.59
Utilization management opportunities for palivizumab for prophylaxis of respiratory syncytial virus complications in infants
Comment on
-
Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization.J Manag Care Pharm. 2010 Jan-Feb;16(1):15-22. doi: 10.18553/jmcp.2010.16.1.15. J Manag Care Pharm. 2010. PMID: 20044843 Free PMC article.
-
Medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan.J Manag Care Pharm. 2010 Jan-Feb;16(1):23-31. doi: 10.18553/jmcp.2010.16.1.23. J Manag Care Pharm. 2010. PMID: 20044844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical